Hetero Biopharma

Hetero Biopharma Company Intelligence, Employees & Workforce Signals

People graph depth
85 signals
Deep profile graph across 6 mapped departments.
Account research
6 steps
Account research checklist combines best covered outreach path, buying-committee coverage, ICP fit, technology workforce evidence, related-company graph, and domain trust; raw contact values are hidden.
Technology talent
5
Technology-oriented role signals in the workforce graph.
Outreach path
General + Manager
Coverage combines 2 visible General contact signals and 3 contactable Manager decision-maker signals.
Evidence quality 100/100 Priority intelligence record

AeroLeads company intelligence

Hetero Biopharma workforce intelligence signals

Evidence from AeroLeads company records, matched professional profiles, and related company graph.

High confidence
Intelligence completeness
Strong intelligence record
8 of 11 major intelligence groups are available for this company.
Largest mapped team
IT
6 profile signals in IT.
Departments mapped
6
Workforce composition from AeroLeads profile data.
Profile graph
Deep profile graph
85 mapped workforce signals against a 106 employee size estimate.
Top reachable team
General
2 visible contact signals.
Top seniority band
Manager
10 of 21 classified profile signals.
Technology talent
6
Technology roles and departments found in workforce signals.

Profile graph researchability

Visible people graph includes 22 visible people: 22 named, 21 titled, 20 located, and 4 contactable.

Research-ready profile graph
Profile coverage evidence tier: Deep profile coverage evidence. Profile coverage evidence combines 85 mapped workforce signals, 106 employee size estimate, and 80.2% profile graph coverage.
High-confidence profile graph evidence: Researchability is based on 22 visible people with 4 populated evidence dimensions: named, titled, located, and contactable signals.
Profile association confidence: Profile association sample. Association confidence combines 21 titled profiles and 4 contactable profiles.
People
22
Named
22
Titled
21
Located
20
Contactable
4

Data methodology

AeroLeads renders only source-backed fields for this company page.

5 source groups
Company record Matched profile graph Email-pattern aggregate Related company graph Company signal fields
Blank source fields are omitted
Related companies are ordered deterministically
Structured data uses aggregate counts only

Intelligence completeness

8 of 11 major intelligence groups are available for this company.

8 / 11 groups
Strong intelligence record 72.7%
Workforce composition Contactability Email intelligence Decision makers Buying committee Technology talent Domain confidence Market and peer context

Evidence quality

This page clears the 60+ AeroLeads company-intelligence evidence threshold.

100 / 100
Priority intelligence record Threshold 60+
Workforce composition Department contactability Department contactability heatmap Department seniority map Business function mix Functional team estimates
Workforce graph
26 signals
Workforce composition, Department contactability, Department contactability heatmap
Source trust
11 signals
Functional team estimates, Functional coverage gap, Domain confidence
Contactability
7 signals
Multi-function contactability, Company email sample, Contact data safety guardrail
Decision-maker intelligence
9 signals
Decision-maker coverage, Leadership signals, Department leadership coverage
Technology intelligence
2 signals
Technology talent, Technology role diversity
Market and peer context
13 signals
Related company graph, Peer graph strength, Peer position benchmark
Company momentum
2 signals
Company signal breadth, Company ownership signal
64 additional source-backed evidence signals are counted in this page quality score.

Prospecting readiness

Hetero Biopharma shows actionable prospecting fit based on best covered outreach path, decision-maker coverage, technology workforce evidence, and people graph depth.

60 / 100
Actionable prospecting fit High-confidence prospecting evidence

Prospecting evidence combines best covered outreach path, decision-maker coverage, technology workforce evidence, people graph depth, and peer context; raw contact values are hidden.

ICP fit
Qualified ICP fit

ICP fit combines company size, market specificity, buying committee, technology path, and people graph depth; raw contact values are hidden.

68 / 100
Company size
106 employees
Employee estimate is in a common outbound prospecting range.
Market specificity
Tagged market profile
2 category and specialty signals in the company record.
Buying committee
Mapped buying committee
Mapped decision-maker signals span 1 business function.
Technology path
Mapped technology evidence
5 matched technology role signals found in the workforce graph.
People graph depth
Deep profile graph
85 mapped workforce signals against a 106 employee size estimate.
Account research checklist
Multi-step account research checklist

Account research checklist combines best covered outreach path, buying-committee coverage, ICP fit, technology workforce evidence, related-company graph, and domain trust; raw contact values are hidden.

6 steps
Confirm contact path
General + Manager
Outreach path evidence combines 2 visible General contact signals and 3 contactable Manager decision-maker signals; raw contacts are hidden.
Map reachable buying committee
Mapped buying committee
Buying-committee evidence combines 1 mapped buying-committee function, 1 contactable function, and Sales / revenue function coverage.
Validate ICP fit
Qualified ICP fit
ICP fit combines company size, market specificity, buying committee, technology path, and people graph depth; raw contact values are hidden.
Review technology path
Mapped technology evidence
5 matched technology role signals found in the workforce graph.
Compare related peers
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
Check domain trust
Mixed domain alignment
Domain evidence combines website domain and social profile; raw email addresses are hidden.
Best outreach path
General + Manager
Coverage combines 2 visible General contact signals and 3 contactable Manager decision-maker signals.
Decision-maker coverage
Mapped buying committee
Mapped decision-maker signals span 1 business function.
Technology contact path
Mapped technology evidence
5 matched technology role signals found in the workforce graph.
People graph depth
Deep profile graph
85 mapped workforce signals against a 106 employee size estimate.
Person-level contact coverage missing: No visible people on this page include email or phone contact evidence.

Domain trust signals

Domain confidence for heterobiopharma.com is based on website domain and social profile.

35 / 100
Mixed domain alignment Limited domain evidence

Domain evidence combines website domain and social profile; raw email addresses are hidden.

Website domain
heterobiopharma.com
The official website domain is available from the company source record.
Social profile
LinkedIn organization page
A LinkedIn organization page is present for this company record.
Employee email mismatch: Visible employee email signals do not match the official domain.

AeroLeads coverage snapshot

Profile sample
4
Visible people attached to this company page.
Profile graph depth
Deep profile graph
85 mapped workforce signals against a 106 employee size estimate.
Department coverage
6
Departments represented in AeroLeads workforce signals.
Department concentration
Department-concentrated workforce
Most mapped workforce signals are in General.
Leadership signals
11
Department lead or leadership signals in the org data.
Department leader sample
Department leader sample
AeroLeads source data includes 10 leadership signals across 2 departments; rows show titles and contact-channel presence only.
Department leadership coverage
Focused department leadership coverage
Leadership signals appear in 2 of 6 mapped departments.
Leadership density
12.90
Percent of mapped department signals that are leadership signals.
Department contact coverage
3
Departments with visible contact samples.
Department contact spread
Focused department contact spread
Visible contact samples appear in 3 of 6 mapped departments.
Department contactability heatmap
Email and phone department contact map
Department samples show 3 email signals and 1 phone signal across 3 contactable departments.
Department seniority map
Multi-department seniority map
Visible department samples map 19 seniority-classified profiles across 6 departments and 2 seniority bands.
Technology talent
5
Visible profiles matching technology role patterns.
Technology evidence confidence
Mapped technology evidence
5 matched technology role signals found in the workforce graph.
Technology department signals
6
Mapped department profile signals in technology-oriented teams.
Email domain confidence
Non-official email coverage
Visible email signals use non-official domains only.
Domain confidence
Mixed domain alignment
Domain confidence for heterobiopharma.com is based on website domain and social profile.
Contact data safety
Limited privacy-safe contact intelligence
AeroLeads exposes contact counts, channel mix, freshness, and domain-alignment evidence while hiding raw email addresses and masking phone numbers in public output.
Company signal breadth
Two-signal company record
Company-level signals include social audience and ownership.
Company ownership signal
Private company record
Company source record includes source type Privately Held.
Audience density
Moderate audience density
2.35K followers against 106 employee estimate, about 22.10 followers per estimated employee.
Specialty signals
1
Specialty tags in the company record.
Market specificity
Tagged market profile
2 category and specialty signals in the company record.
Peer industry clusters
2
Industries represented by related company records.
Related companies
9
Company graph links available for comparison.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 9 related companies, 8 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Peer benchmark confidence
Multi-signal peer benchmark evidence
Peer benchmark combines 9 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Peer position benchmark
Employee-scale peer position benchmark
Peer-position benchmark shows employee scale above 0% of 9 comparable related peers.
Peer comparison matrix
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
Workforce locations
8
Locations represented in visible profile signals.
Workforce distribution
Multi-location workforce
Visible profile location signals span 8 locations, led by Hyderabad, Telangana, India.
Workforce location footprint
Multi-country workforce footprint
Visible profile locations span 8 cities across 2 countries, led by Hyderabad.
Workforce distribution model
Multi-country workforce model
Visible profile locations span 2 countries, led by Hyderabad, Telangana, India at 55% of visible location signals.
Workforce geography evidence confidence
Corroborated workforce geography evidence
Workforce geography spans 8 locations across 20 visible profile signals, with reachable evidence across 4 locations.
Contactable workforce locations
4
Workforce locations represented by visible contact samples.
Top contactable workforce location
Bengaluru, Karnataka, India
Visible contact samples span 4 workforce locations, led by Bengaluru, Karnataka, India.
Workforce seniority tiers
3
Seniority bands derived from visible profile titles and levels.
Seniority evidence confidence
Corroborated seniority evidence
Seniority graph spans 21 classified profile signals across 3 tiers, with reachable evidence for 4. Balanced management-to-IC sample.
Classified seniority profiles
21
Visible profiles with usable seniority signals.
Management-to-IC proxy
Balanced management-to-IC sample
10 managerial seniority signals and 11 contributor signals appear in the visible seniority-classified sample.
Role title diversity
Diverse role title sample
21 distinct role titles across 21 visible titled profiles.
Visible role titles
21
Distinct role titles found in visible profile signals.
Business function mix
Broad business-function workforce sample
AeroLeads maps 8 visible profile signals into 4 business functions; 2 include visible contact data.
Mapped business functions
4
Business functions inferred from visible profile titles and departments.
Functional team estimates
Revenue and engineering team estimates
AeroLeads derives 1 visible revenue team profile signal and 5 visible engineering team profile signals from mapped business-function signals.
Functional coverage gaps
Broad function coverage with visible gaps
Visible people signals cover 4 of 8 core business functions. Not observed in the visible graph: Marketing / growth, Product / design, Operations, and Customer / support. Treat this as a coverage gap, not confirmed absence.
Contactable role titles
4
Distinct role titles with visible contact samples.
Contactable role coverage
Diverse contactable role coverage
4 reachable role titles across 4 contactable titled profiles.
Decision-maker signals
11
Visible profiles matching seniority or leadership title patterns.
Decision-maker reachability
Partial decision-maker reachability
Some mapped decision-maker signals include visible contact data.
Buying committee evidence confidence
Mapped buying committee
Mapped decision-maker signals span 1 business function.
Buyer persona availability
Single-persona buyer availability
Mapped decision-maker evidence covers Revenue buyer; 1 of 1 buyer persona include visible contact data.
Decision-maker contactability rate
27.30
Percent of mapped decision-maker signals with visible contact data.
Best covered outreach path
General + Manager
Coverage combines 2 visible General contact signals and 3 contactable Manager decision-maker signals.
Prospecting fit
Actionable prospecting fit
Hetero Biopharma shows actionable prospecting fit based on best covered outreach path, decision-maker coverage, technology workforce evidence, and people graph depth.
ICP fit
Qualified ICP fit
Hetero Biopharma matches the qualified ICP fit band for common outbound filters based on company size, market specificity, buying committee, technology path, and people graph depth.
Account research checklist
Multi-step account research checklist
Account research checklist combines best covered outreach path, buying-committee coverage, ICP fit, technology workforce evidence, related-company graph, and domain trust; raw contact values are hidden.
Intelligence signal groups
23
AeroLeads signal groups available for this company.

Market focus signals

Primary industry
Pharmaceutical Manufacturing
Market specificity
Tagged market profile
2 category and specialty signals in the company record.
Market evidence tier
Corroborated market evidence
Market evidence combines 4 classification signals from categories, specialties, and related peer industries.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 9 related companies, 8 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Top peer industry
Pharmaceutical Manufacturing
88% of 9 related peer industry signals.
Peer benchmark evidence
Multi-signal peer benchmark evidence
Peer benchmark combines 9 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Size position
Smaller than most related peers
9 of 9 related employee-estimated peers are higher.
Peer graph strength
Benchmark-ready peer graph
Related peer graph has industry context, employee benchmarks, website records, and social profiles across 9 related companies.
Benchmark dimensions: peer graph strength, size benchmark, and size position.
Categories
Pharmaceutical Manufacturing
Specialties
in Biosimilars
Product-market keyword evidence
Limited market keywords
Keyword evidence comes from 2 source field groups: Category, Specialty.
Product-market keyword evidence tier: Limited product-market keyword evidence. Product-market keyword evidence combines 2 unique market keywords and 2 source field groups (1 category and 1 specialty).
Pharmaceutical Manufacturing · Category in Biosimilars · Specialty
Related peer industries
Peer-industry evidence tier: High-confidence peer-industry evidence. Peer-industry evidence combines 9 related companies, 2 peer-industry clusters, and top peer industry Pharmaceutical Manufacturing at 88.9%.
Functional coverage gaps
Broad function coverage with visible gaps
Visible people signals cover 4 of 8 core business functions. Not observed in the visible graph: Marketing / growth, Product / design, Operations, and Customer / support. Treat this as a coverage gap, not confirmed absence.
Transparent function coverage evidence: Function coverage evidence combines observed functions Sales / revenue, Technology / data, People / HR, and Finance and 4 unobserved core functions in the visible graph.
Pharmaceutical Manufacturing 8 peers
88.9% of related peer industries
Biotechnology Research 1 peer
11.1% of related peer industries

Company signals

Company signal breadth
Two-signal company record
Company-level signals include social audience and ownership.
Corroborated company record evidence: Company record evidence combines 2 source-backed company signal types: social audience and ownership.
Social audience
2.35K
Followers in the company source record.
Social audience evidence tier: Limited social-audience evidence. Social audience evidence uses 2.35K followers from source field social_followers.
Audience density
Moderate audience density
2.35K followers against 106 employee estimate, about 22.10 followers per estimated employee.
Audience-density evidence tier: Corroborated audience-density evidence. Audience-density evidence combines 2.35K social followers, 106 employee estimate, and 22.10 followers per estimated employee.
Company ownership
Private company record
Company source record includes source type Privately Held.
Company ownership evidence tier: Structured ownership evidence. Ownership evidence combines source type Privately Held from structured company source fields.

Workforce composition

Department concentration
Department-concentrated workforce
Most mapped workforce signals are in General. 87.1% of mapped department signals are in the largest department.
Department concentration evidence tier: Concentrated department evidence. Department concentration evidence combines 6 mapped departments, top department General, and 87.1% top-department share.
Department leadership coverage
Focused department leadership coverage
Leadership signals appear in 2 of 6 mapped departments. Leadership signals represent 12.9% of mapped department signals.
Department leadership evidence tier: Corroborated department leadership evidence. Department leadership evidence combines 11 leadership signals, 2 of 6 mapped departments, and 12.9% leadership density.
Department seniority map
Multi-department seniority map
Visible department samples map 19 seniority-classified profiles across 6 departments and 2 seniority bands.
Department seniority evidence tier: High-confidence department seniority evidence. Department seniority evidence combines 19 seniority-classified profiles, 6 departments, 2 seniority bands, and top cell General + Manager with 8 profiles.
General 9 profiles
Manager: 8 Individual contributor: 1
IT 5 profiles
Individual contributor: 5
Operations 2 profiles
Individual contributor: 2
HR 1 profile
Individual contributor: 1
Legal 1 profile
Individual contributor: 1
Sales 1 profile
Manager: 1
11 leadership signals 3 departments with visible contacts
Department leader sample
Department leader sample
3 contactable

AeroLeads source data includes 10 leadership signals across 2 departments; rows show titles and contact-channel presence only.

Department leader evidence tier: High-confidence department leader evidence. Department leader evidence combines 10 leadership signals, 2 departments, and 3 contactable; raw contacts are hidden.
Leader Department Seniority Channel
VENKATA SUDHEERREDDY ALLA
Manager at Hetero Biopharma
General Manager Email
faize Beg
Deputy Manager at Hetero Biopharma Ltd
General Manager Email
Richard Effiong
Biochemist - Sales Strategist - Business Manager - Advocacy
Sales Manager Phone
Abdul Rahim
Manager - Microbiology at Hetero Biopharma
General Manager No visible contact channel
Prattipati Mahesh
Senior Manager at Hetero Biopharma
General Manager No visible contact channel
Suryanarayana Vegesna
Deputy Manager at Hetero Biopharma
General Manager No visible contact channel
General 74 signals
87.1% of mapped department signals, 10 leadership signals, 2 visible contacts
IT 6 signals
7.1% of mapped department signals
Operations 2 signals
2.4% of mapped department signals, 1 visible contact
HR 1 signals
1.2% of mapped department signals
Legal 1 signals
1.2% of mapped department signals
Sales 1 signals
1.2% of mapped department signals, 1 leadership signals, 1 visible contact

Technology talent signals

5 matched technology role signals.

Technology evidence tier
Mapped technology evidence
5 matched technology role signals found in the workforce graph.
6 IT department signals
Technology role mix
Multi-area technology role mix
Matched technology signals span Engineering and Data / AI role groups.
Technology role evidence tier: Multi-area technology role evidence. Technology role evidence combines 5 matched technology role signals, 2 technology role groups, and Engineering and Data / AI.
Engineering 4 profiles
80.0% of matched technology role signals
Data / AI 1 profile
20.0% of matched technology role signals
Matched role examples
Engineer at Hetero Biopharma 1
Process Engineer at Finished Product Hetero Biopharma 1
Process Engineer at Hetero Biopharma 1
Mechanical Engineer 1

Workforce seniority mix

Aggregated from 21 classified profile signals.

Largest seniority band
Manager
10 of 21 classified profile signals, 3 with visible contact data.
Corroborated seniority evidence: Seniority graph spans 21 classified profile signals across 3 tiers, with reachable evidence for 4. Balanced management-to-IC sample.
Management-to-IC proxy
Balanced management-to-IC sample
47.6%
managerial seniority signals
52.4%
contributor seniority signals
10 managerial seniority signals and 11 contributor signals appear in the visible seniority-classified sample.
Management-shape evidence tier: Balanced management-shape evidence. Management-shape evidence combines 21 seniority-classified signals, 10 managerial signals, 47.6% managerial share, and 11 contributor signals.
Manager 10 profiles
47.6% of classified seniority signals, 3 with visible contact data
Individual contributor 10 profiles
47.6% of classified seniority signals, 1 with visible contact data
Senior / Lead 1 profile
4.8% of classified seniority signals

Workforce geography

Aggregated from 20 visible profile location signals.

Workforce geography evidence
Corroborated workforce geography evidence
Workforce geography spans 8 locations across 20 visible profile signals, with reachable evidence across 4 locations.
Distribution signal
Multi-location workforce
Visible profile location signals span 8 locations, led by Hyderabad, Telangana, India.
Workforce distribution model
Multi-country workforce model
Visible profile locations span 2 countries, led by Hyderabad, Telangana, India at 55% of visible location signals.
Corroborated workforce model evidence: Workforce model evidence combines 20 located profile signals, 8 workforce locations, 8 cities, 2 countries, top hub Hyderabad, Telangana, India at 55%, and 4 reachable locations.
Locations
8
Countries
2
Top hub share
55%
Workforce location footprint
Multi-country workforce footprint
Visible profile locations span 8 cities across 2 countries, led by Hyderabad.
Cities
8
Countries
2
Contactable location spread
Multi-location contact coverage
Visible contact samples span 4 workforce locations, led by Bengaluru, Karnataka, India.
Contactable location evidence tier: Multi-location contactable evidence. Contactable location evidence combines 4 contactable profile location signals, 4 workforce locations, and top contactable hub Bengaluru, Karnataka, India at 25.0%.
Bengaluru, Karnataka, India 1 contact
25.0% of contactable location signals
Jadcherla, Telangana, India 1 contact
25.0% of contactable location signals
Hyderabad, Telangana, India 1 contact
25.0% of contactable location signals
Abuja, Federal Capital Territory, Nigeria 1 contact
25.0% of contactable location signals
Hyderabad, Telangana, India 11 profiles
55.0% of visible location signals
Telangana, India 2 profiles
10.0% of visible location signals
Bengaluru, Karnataka, India 2 profiles
10.0% of visible location signals
India 1 profile
5.0% of visible location signals
Jadcherla, Telangana, India 1 profile
5.0% of visible location signals
Mahabubnagar, Telangana, India 1 profile
5.0% of visible location signals

Decision-maker coverage

11 seniority signals, 3 with visible contact data.

Decision-maker evidence tier
Mapped decision-maker evidence
Decision-maker evidence covers 11 seniority signals, 3 reachable. Buying committee spans 1 function.
Account planning snapshot
Multi-signal account planning snapshot
Snapshot combines department reachability, decision-maker coverage, and buying-committee function aggregates.
4 account-planning evidence cards available.
Account planning evidence tier: Multi-source account planning evidence. Account planning evidence combines 4 aggregate account-planning cards, best covered outreach path, 1 reachable buying-committee function, Manager seniority reachability, and General department contactability; raw contacts are hidden.
Best covered path
General + Manager
Coverage combines 2 visible General contact signals and 3 contactable Manager decision-maker signals.
Reachable buying committee
1 of 1 functions
Reachable functions include Sales / revenue.
Most reachable seniority
Manager
3 of 10 signals in this seniority band include visible contact data.
Top reachable team
General
2 visible contact signals in this department sample.
Partial decision-maker reachability 27.3%
Some mapped decision-maker signals include visible contact data.
Decision-maker reachability evidence tier: Partial decision-maker reachability evidence. Decision-maker reachability evidence combines 3 contactable decision-maker signals, 11 mapped decision-maker signals, and 27.3% contactability.
Email and phone decision-maker coverage: Mapped decision-maker signals include 2 email signals, 1 phone signal, and 0 with both channels.
Buying committee function coverage
Single-function buying-committee coverage
1 of 1 mapped functions include visible decision-maker contact data.
Mapped buying committee: Mapped decision-maker signals span 1 business function.
Buying committee evidence tier: Mapped buying-committee evidence. Buying-committee evidence combines 1 mapped buying-committee function, 1 contactable function, and Sales / revenue function coverage.
Buyer persona availability: Single-persona buyer availability. Mapped decision-maker evidence covers Revenue buyer; 1 of 1 buyer persona include visible contact data. Reachable buyer persona evidence: Buyer persona evidence combines 1 mapped buyer persona, 1 contactable persona, and Revenue buyer coverage.
Sales / revenue: 1 contactable
Most reachable seniority
Manager
3 of 10 seniority signals include visible contact data.
Seniority reachability evidence tier: Corroborated seniority reachability evidence. Seniority reachability evidence combines 3 contactable Manager signals, 10 Manager signals, 30.0% tier contactability, and email and phone coverage.
Manager 10 profiles
90.9% of mapped seniority signals, 3 with visible contact data
Senior / Lead 1 profile
9.1% of mapped seniority signals

Role and function mix

21 visible titled profiles across 21 distinct role titles.

Title mix
Diverse role title sample
21 distinct role titles across 21 visible titled profiles.
Role-title evidence tier: Diverse role-title evidence. Role-title diversity evidence combines 21 visible titled profiles, 21 distinct role titles, and top title Agm - Procurement @Hetero Biopharma Ltd. at 4.8%.
Business function mix
Broad business-function workforce sample
AeroLeads maps 8 visible profile signals into 4 business functions; 2 include visible contact data.
Business-function evidence tier: Corroborated business-function evidence. Business-function evidence combines 8 mapped function profile signals, 4 business functions, 2 contactable signals, 2 contactable functions, and top function Technology / data at 62.5%.
Multi-function contactability map 2 / 4 functions
2 of 4 mapped business functions include visible contact data.
Functional team estimates
Revenue and engineering team estimates
AeroLeads derives 1 visible revenue team profile signal and 5 visible engineering team profile signals from mapped business-function signals.
Corroborated functional team evidence: Functional team estimate evidence combines 1 visible revenue team profile signal and 5 visible engineering team profile signals.
Revenue team estimate 1 profile
12.5% of mapped function signals, 1 with visible contact data; Sales / revenue
Engineering team estimate 5 profiles
62.5% of mapped function signals; Technology / data
Technology / data 5 profiles
62.5% of mapped function signals
Finance 1 profile
12.5% of mapped function signals, 1 with visible contact data
People / HR 1 profile
12.5% of mapped function signals
Sales / revenue 1 profile
12.5% of mapped function signals, 1 with visible contact data
Contactable role coverage
Diverse contactable role coverage
4 reachable role titles across 4 contactable titled profiles.
Contactable role evidence tier: Diverse contactable role evidence. Contactable role evidence combines 4 contactable titled profiles, 4 reachable role titles, and top reachable role Agm - Procurement @Hetero Biopharma Ltd. at 25.0%.
Role title reachability
Broad role-title reachability
4 of 21 distinct visible role titles include email or phone signals.
Role-title reachability evidence tier: Corroborated role-title reachability evidence. Role-title reachability evidence combines 21 visible role titles, 4 reachable titles, and 19.0% title reachability.
Agm - Procurement @Hetero Biopharma Ltd. 1 profile
4.8% of visible titled profiles
Biochemist - Sales Strategist - Business Manager - Advocacy 1 profile
4.8% of visible titled profiles
Deputy Manager at Hetero Biopharma 1 profile
4.8% of visible titled profiles
Deputy Manager at Hetero Biopharma Ltd 1 profile
4.8% of visible titled profiles
Deputy Manager in Packaging Development @ Hetero Biopharma Limited 1 profile
4.8% of visible titled profiles
Deputy Manager in Quality Control Microbiology 1 profile
4.8% of visible titled profiles

Contactability signals

Contact data safety
Limited privacy-safe contact intelligence
AeroLeads exposes contact counts, channel mix, freshness, and domain-alignment evidence while hiding raw email addresses and masking phone numbers in public output.
Aggregate signals
2
Channel coverage
Email aggregate coverage
Evidence groups
1
Limited contact-safety evidence: Contact-safety evidence combines company email sample; public schema uses aggregate variables only.
Aggregate-only contact schema: Dataset variables use counts, rates, channel labels, freshness bands, and domain-alignment metrics instead of raw contact values.
Best covered outreach path
General + Manager
Coverage combines 2 visible General contact signals and 3 contactable Manager decision-maker signals.
Outreach path evidence tier: Corroborated outreach path evidence. Outreach path evidence combines 2 visible General contact signals and 3 contactable Manager decision-maker signals; raw contacts are hidden.
Visible people
4
Company email sample
Limited company email sample
AeroLeads source data includes 2 email records across 1 domain; raw addresses are hidden.
Source email evidence tier: Multi-domain source email evidence. Source email evidence combines 2 unique source email records and 1 domain.

Email domain intelligence

0 of 4 visible email signals match heterobiopharma.com.

Non-official email coverage: Visible email signals use non-official domains only.
Email identity evidence tier: Non-official email identity evidence. Email identity evidence combines 4 visible email signals, 2 other-domain signals, and 2 personal-domain signals.
0.0% domain match 0 people with official-domain email 4 non-official email signals

Department contact samples

Focused department contact spread: Visible contact samples appear in 3 of 6 mapped departments.
Department contactability evidence tier: High-confidence department contactability evidence. Department contactability evidence combines 4 visible contact samples, 3 of 6 mapped departments, 3 email signals, and 1 phone signal; raw contacts are hidden.
Contactability heatmap
Email and phone department contact map
Department samples show 3 email signals and 1 phone signal across 3 contactable departments.
General Email
Email2
Phone0
Operations Email
Email1
Phone0
Sales Phone
Email0
Phone1
Department Contacts Email Official email Phone
General 2 2 0 0
Operations 1 1 0 0
Sales 1 0 0 1

Company source details

Employees
106
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
in Biosimilars.

Hetero Biopharma Questions

News

Hetero Biopharma Gets CDSCO Panel Nod for Phase IV Trial of Denosumab Injection in Cancer Patients - Medical Dialogues

Hetero Biopharma Gets CDSCO Panel Nod for Phase IV Trial of Denosumab Injection in Cancer Patients Medical Dialogues

Hetero Biopharma deploys Transcell-Quantiphi's digital animal replacement technology for drug development - BioSpectrum India

Hetero Biopharma deploys Transcell-Quantiphi's digital animal replacement technology for drug development BioSpectrum India

Hetero Biopharma gets CDSCO panel nod to market, manufacture Tenecteplase - Medical Dialogues

Hetero Biopharma gets CDSCO panel nod to market, manufacture Tenecteplase Medical Dialogues